A European research group has developed an algorithm that enables 3d printed Cannabidiol (CBD) products. 

Using newly created processes, one can create capsules that melt, often referred to as “orodispersible films.” These capsules can be created with sizes and dosages that are customized to the patient. This process has already been used with 3d printing devices. Experts claim that, in time, the tech should be readily available through various avenues. Hospitals, pharmacies and even homes can potentially have the technology once it’s established. 

The research group holds the premise that CBD has the potential for abuse. This point of view is in contradiction with other experts who claim that the real addicting component in cannabis is THC. Others feel neither component has the potential for addiction. Nevertheless, their hope is that, with personalization of the drug, the potential for abuse can be avoided.

Whether one agrees that CBD and THC has the potential for addiction, the benefits of 3D customization go beyond helping potential abuse. The customization that can be achieved can be strategized based on age, diet, and condition. The research group believes that these achievements can improve chances of survival.

Because much of the drug market involves making medications on a massive scale, the concept of customization, though present, is seen as limited. As a result, this research group  

Using the patient’s weight, age and other pertinent factors, the research group has developed an algorithm to make a 3d model for a tablet catered to the patient. 

One of the challenges facing the CBD industry is the challenge of providing consistent and accurate measurements of pertinent ingredients. For example, federally legal CBD oil must contain no more than .3% THC. You might see a packet of lotion that says 1000mg of CBD on the label. Yet it might surprise you that the actual measurement could be 984mg. 

When talking about today’s pharmaceutical market, measured ingredients rarely deviate to this extent from the labeled amounts. Nevertheless, CBD, hemp, and cannabis products are all mainly derived from one source. This source is a plant that does not want to be controlled. Even with the best of farming practices, the unpredictable can occur. The current state of this newly formed industry has lead to a temporary “acceptance” that 1000mg could actually be 984mg. A 10-20% shift between what’s on the label and what’s in the product is not unfathomable. 

While the potential is promising, members of the research group acknowledge that more needs to be done. One area of improvement is the need for a more detailed algorithm; specifically more parameters about the patients condition. However, in the age of cyberattacks, many are concerned about the negative impact of more patient information on the internet. 

There has already been progress in 3d printing in the mainstream pharmaceutical market. Opiod tablets have been made with properties that inhibit addiction. While more research must take place, scientists are hopeful that a new drug can be developed to combat the oppiod crisis. There have also been attempts to combine multiple prescriptions into one pill.